• Forbion's BioEconomy team contributed to Invest-NL's report on bringing agricultural and food biotechnology innovations to market in the Netherlands.
• Market demand drives adoption; new ingredients must compete on cost, quality and performance, as sustainability alone rarely prompts manufacturers to switch.
• Public funding can help close scale-up financing gaps once credible commercial evidence is established.
• The analysis draws on more than 150 interviews and 15 years of investment data.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Forbion Capital Partners Management Services BV published the original content used to generate this news brief on November 03, 2026, and is solely responsible for the information contained therein.